.svg){kind=small}
Where to Buy
Dreamt is stocked at 33 licensed dispensaries across Colorado, Virginia, and 5 other states, 12 of them in Colorado, with the deepest coverage in Aurora, Denver, Edgewater, Fort Collins, and Glenwood Springs. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Edible holds 86.03% share in August 2026 with year-over-year growth of 20.54% and month-over-month decline of 4.60%, while Tincture & Sublingual accounts for 13.97% share with year-over-year growth of 99.00% and month-over-month increase of 18.40%. Despite brand-level sales growth of 27.56% year over year and a 22.66% drop in average price, the category split is widening at the margins as Tincture & Sublingual expands faster than the Edible core. Dreamt’s August 2026 rank of 54 in Edible in New Jersey pairs with Edible’s month-over-month decline and Tincture & Sublingual’s acceleration to indicate a mixed near-term cadence within a still Edible-led portfolio.
The shift—Edible down 4.60% month over month against Tincture & Sublingual up 18.40%, and 20.54% versus 99.00% year over year—implies a gradual diversification away from single-category dependency, with price elasticity likely aiding Tincture & Sublingual trial at a $13.58 average versus $15.31 in Edible. With Edible still at 86.03% share but trailing the brand’s 27.56% year-over-year growth rate, Dreamt’s positioning is moving from an Edible-first identity toward a broader sleep-adjacent format set, where incremental share gains in Tincture & Sublingual can buffer rank volatility in the New Jersey Edible ranking at 54.
Competitive Landscape
Dreamt ranks #54 in New Jersey Edible for August 2026, unchanged year over year from #54, while slipping 1 position from May 2026’s #53 and sitting 12 spots below its peak of #42 from February 2025; by contrast, Gron / Grön holds #1 with a -19.9% year-over-year sales change and Wyld holds #2 with an -8.6% year-over-year sales change, indicating top-tier stability despite declines. Meanwhile, OGEEZ advanced from #7 to #4 alongside an 18.0% year-over-year sales increase, while Select stayed at #3 with a -30.0% year-over-year sales decline, suggesting that mobility is occurring mid-pack even as the top two remain static. The pattern implies Dreamt’s flat rank trajectory at #54, combined with minor short-term slippage and competitors’ mixed movement, points to stalled share capture unless activation targets mid-pack volatility for entry points.
Notable Products
CBD/THC/CBN 2:5:1 Honey Lemon Soft Lozenge 20-Pack (40mg CBD, 100mg THC, 20mg CBN) posted the steepest decline at -93.6% MoM, sliding to rank 6 while the CBD/THC/CBN 2:5:1 Honey Lemon Gummies 20-Pack (40mg CBD, 100mg THC, 20mg CBN) jumped +59.3% MoM to rank 1. The CBD/CBN/THC 4:2:1 Midnight Berry Gummies (40mg CBD, 20mg CBN, 100mg THC) fell -22.0% to rank 2, and the Honey Lemon Gummies 2-Pack (20mg) dropped -43.1% at rank 4, signaling uneven traction across dose sizes. Four of the top six products are Edibles, concentrating volume in formats where one hero gummy alone generated $11,999 in August 2026 while lozenges at both 10-Pack and 20-Pack formats declined -66.7% and -93.6%, respectively. The pattern implies Dreamt’s commercial direction is consolidating around gummy SKUs with balanced CBD:THC:CBN ratios, while lozenges lose shelf efficiency and should be pruned or reformulated.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
